Part B Insider - 2021 Issue 9
Reader Questions: Look to Criteria for Drug Therapy
Subscribe or sign in to view the full article.
Article Overview
This reader Q&A examines the broad CPT framework for determining when drug therapy monitoring may support a higher level of medical decision making. It also compares that topic with Medicare guidance on prescription drug management and discusses the kind of documentation referenced by the article. The piece is useful for coders, auditors, and clinicians who need a clearer sense of the documentation concepts involved without relying on assumptions about medication follow-up.
Why This Topic Matters
Understanding how drug therapy monitoring is treated in MDM helps support accurate note review and level-of-service selection. The article also highlights how CPT and Medicare guidance are discussed together when evaluating documentation for medication management.
What You Will Learn
- How the article frames drug therapy monitoring within MDM documentation review.
- How CPT guidance and Medicare prescription drug management are discussed in relation to medication follow-up.
- What kinds of documentation concepts the article says are relevant to assessing medication management notes.
- How the article contrasts monitoring for adverse effects with general treatment follow-up.
Who Should Read This
- Medical coders
- Coding auditors
- Physicians and other clinicians
- Billing and compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com